GENE ONLINE|News &
Opinion
Blog

Genentech
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
Genentech Unveils Positive Two-Year Data For Spinal Muscular Atrophy Drug
2022-10-13
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Genentech Bets $650 Million Biobucks on China’s Jemincare’s Prostate Cancer Prospect
2022-08-19
Roche Looks for Peptide-Like Small Molecules with Prism BioLab, joining Merck, Eisai and Boehringer Ingelheim
2022-01-05
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
Japan’s SoftBank Buys $5 billion Stake in Roche, Becoming One of its Largest Investors
2021-08-05
Pieris Pharma Teams up With Genentech to Take On the Respiratory and Ophthalmology Markets
2021-05-26
T Cells and Cancer: Uncovering the Unknowns
2021-04-16
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Genentech Seeks FDA’s Blessings after Adjuvant Tecentriq Shows Promising Result in Lung Cancer Patients
2021-03-23
1 2 3
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
EVENT
Scroll to Top